Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in the heart, peripheral nerves, and other tissues and organs.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
18 June 2022
|
| In: |
Orphanet journal of rare diseases
Year: 2022, Jahrgang: 17, Pages: 1-12 |
| ISSN: | 1750-1172 |
| DOI: | 10.1186/s13023-022-02359-w |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13023-022-02359-w |
| Verfasserangaben: | Angela Dispenzieri, Teresa Coelho, Isabel Conceição, Márcia Waddington-Cruz, Jonas Wixner, Arnt V. Kristen, Claudio Rapezzi, Violaine Planté-Bordeneuve, Juan Gonzalez-Moreno, Mathew S. Maurer, Martha Grogan, Doug Chapman and Leslie Amass on behalf of the THAOS investigators |
| Zusammenfassung: | Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in the heart, peripheral nerves, and other tissues and organs. |
|---|---|
| Beschreibung: | Gesehen am 29.08.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 1750-1172 |
| DOI: | 10.1186/s13023-022-02359-w |